We are live on ! Find out more
LPC

Lion Point Capital Portfolio holdings

AUM $20.9M
1-Year Est. Return 195.52%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+195.52%
3 Year Est. Return
+318.83%
5 Year Est. Return
+369%
10 Year Est. Return
+2,361.28%
AUM
$243M
AUM Growth
-$460M
Cap. Flow
+$648K
Cap. Flow %
0.27%
Top 10 Hldgs %
89.97%
Holding
39
New
8
Increased
2
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
SMTC icon
Semtech
SMTC
+$76.7M
2
DNTH icon
Dianthus Therapeutics
DNTH
+$3.15M
3
MRSN
Mersana Therapeutics
MRSN
+$2.3M
4
TSVT
2seventy bio
TSVT
+$1.94M
5
ACRS icon
Aclaris Therapeutics
ACRS
+$1.39M

Top Sells

Rank Stock Value
1
WT icon
WisdomTree
WT
+$26.5M
2
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
+$16.1M
3
EXE
Expand Energy Corp
EXE
+$16M
4
MRNS
Marinus Pharmaceuticals, Inc
MRNS
+$10M
5
INSM icon
Insmed
INSM
+$6.74M

Sector Composition

Rank Sector Weight
1 Miscellaneous 25.34%
2 Technology 24.4%
3 Healthcare 23.03%
4 Energy 18.02%
5 Industrials 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$814B
$61.4M 25.29%
150,000
-907,000
-86% -$362M
SMTC icon
2
Semtech
SMTC
$13.8B
$59.2M 24.38%
+2,452,855
New +$76.7M
CHRD icon
3
Chord Energy
CHRD
$8.01B
$28.5M 11.72%
211,403
– –
ARNC
4
DELISTED
Arconic Corporation
ARNC
$18.7M 7.69%
712,358
-100,000
-12% -$2.46M
MRNS
5
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$18.1M 7.44%
2,620,096
-1,602,552
-38% -$10M
ARDX icon
6
Ardelyx
ARDX
$976M
$9.76M 4.02%
2,036,667
+151,667
+8% +$512K
PDCE
7
DELISTED
PDC Energy, Inc.
PDCE
$8.37M 3.45%
130,398
– –
DRRX
8
DELISTED
DURECT Corp
DRRX
$6.47M 2.66%
1,428,306
– –
CIVI
9
DELISTED
Civitas Resources
CIVI
$4.44M 1.83%
65,000
-50,000
-43% -$3.24M
DNTH icon
10
Dianthus Therapeutics
DNTH
$6.05B
$3.62M 1.49%
+284,904
New +$3.15M
MCRB icon
11
Seres Therapeutics
MCRB
$57.5M
$3.38M 1.39%
29,840
– –
BFI
12
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$3.24M 1.33%
2,745,938
– –
CTIC
13
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$2.53M 1.04%
601,579
-3,101,072
-84% -$16.1M
BATL icon
14
Battalion Oil
BATL
$73.9M
$2.5M 1.03%
380,891
+19,840
+5% +$184K
MIRM icon
15
Mirum Pharmaceuticals
MIRM
$6.15B
$2.33M 0.96%
97,000
– –
TSVT
16
DELISTED
2seventy bio
TSVT
$1.73M 0.71%
+170,000
New +$1.94M
MRSN
17
DELISTED
Mersana Therapeutics
MRSN
$1.68M 0.69%
+16,365
New +$2.3M
MIST icon
18
Milestone Pharmaceuticals
MIST
$149M
$1.68M 0.69%
425,207
– –
KNSA icon
19
Kiniksa Pharmaceuticals
KNSA
$6.08B
$1.22M 0.5%
113,540
-232,960
-67% -$3.07M
ACRS icon
20
Aclaris Therapeutics
ACRS
$908M
$889K 0.37%
+109,898
New +$1.39M
CBAY
21
DELISTED
Cymabay Therapeutics
CBAY
$867K 0.36%
99,425
-120,000
-55% -$961K
INSM icon
22
Insmed
INSM
$27.6B
$858K 0.35%
50,335
-346,834
-87% -$6.74M
ORGN
23
DELISTED
Origin Materials
ORGN
$427K 0.18%
3,333
– –
BLU
24
DELISTED
BELLUS Health Inc.
BLU
$324K 0.13%
45,000
-105,000
-70% -$814K
STSA
25
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
$223K 0.09%
+319,742
New +$294K
1
2

Similar funds

SCM
Stadium Capital Management New Canaan, Connecticut $21M AUM 6.45% 1-Year Est. Return
MPW
MGO Private Wealth Irvine, California $20.7M AUM 18.57% 1-Year Est. Return
FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 16.79% 1-Year Est. Return
VAM
Vazirani Asset Management New York $20.3M AUM 79.33% 1-Year Est. Return
SPC
Stone Point Capital Greenwich, Connecticut $21.7M AUM 48.55% 1-Year Est. Return
SCM
Semanteon Capital Management Newton, Massachusetts $22.2M AUM 53.69% 1-Year Est. Return
HIIL
HS Investments III Ltd St. Peter Port $22.3M AUM
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return

Lion Point Capital's Q1 2023 Portfolio in Review

As of Q1 2023, Lion Point Capital held 39 positions worth $243M, down 65% from $703M the previous quarter. Its ten largest holdings account for 90% of the portfolio.

Lion Point Capital's Q1 2023 filing shows 8 new, 2 increased, 9 reduced and 8 closed positions. Its largest new stake was Semtech: 2,452,855 shares worth $59.2M. The largest sale was WisdomTree, an estimated $26.5M.

By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, down from 74% a quarter earlier, followed by Technology and Healthcare.

  • Lion Point Capital's largest Q1 2023 buy was Semtech: 2,452,855 shares worth $59.2M.
  • Lion Point Capital added most to Ardelyx in Q1 2023, an estimated $512K increase.
  • Lion Point Capital's biggest Q1 2023 reduction was CTI BioPharma Corp. (DE) Common Stock, cutting an estimated $16.1M.
  • Lion Point Capital fully exited WisdomTree in Q1 2023, selling an estimated $26.5M.
  • Lion Point Capital's ten largest holdings make up 90% of its $243M portfolio in Q1 2023.
  • Lion Point Capital opened 8 new positions and closed 8 in Q1 2023.
  • Lion Point Capital's portfolio value fell 65% quarter-over-quarter to $243M.

Based on Lion Point Capital's 13F filing for Q1 2023, filed 15 May 2023.